MAPK3 and neoplasm: Whilst moderate ERK1/2 activity is a well-established pro-proliferative and pro-survival signal[12,13], excessive ERK1/2 signalling can trigger tumour suppressive mechanisms that ultimately lead to cell cycle arrest, senescence and/or cell death[12,14].